Showing results (1-10 of 417) with videos related to
Sort By:
Pageof 42
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2017
Avoidance of On-Target Off-Tumor Activation Using a Co-stimulation-Only Chimeric Antigen ReceptorJonathan Fisher, Pierre Abramowski, Nisansala Dilrukshi Wisidagamage Don, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 10, 2018
Chimeric Antigen Receptor-Engineered Human Gamma Delta T Cells: Enhanced Cytotoxicity with Retention of Cross PresentationAnna Capsomidis, Gabriel Benthall, Heleen H Van Acker, et al.Journal of Pediatric Hematology/Oncology|January 19, 2017
Vocal Cord Palsy in Children With Cancer: A 10-Year Analysis of UK Pediatric Intensive Care AdmissionsAnna Capsomidis, Andrew Hall, Hamid Daya, et al.Frontiers in Immunology|August 10, 2017
CD56 in the Immune System: More Than a Marker for Cytotoxicity?Heleen H Van Acker, Anna Capsomidis, Evelien L Smits, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2014
Neuroblastoma killing properties of Vδ2 and Vδ2-negative γδT cells following expansion by artificial antigen-presenting cellsJonathan P H Fisher, Mengyong Yan, Jennifer Heuijerjans, et al.The Journal of Family Practice|June 19, 2018
The Pharmacokinetic Properties of Glucagon-like Peptide-1 Receptor Agonists and Their Mode and Mechanism of Action in Patients with Type 2 DiabetesJohn AndersonFrontline Gastroenterology|August 26, 2017
The future of gastroenterology training: instruction in technical skillsJohn AndersonPediatric Blood & Cancer|April 7, 2017
Unleashing the immune response against childhood solid cancersJohn AndersonFuture Oncology (London, England)|May 20, 2009
Degarelix: a novel gonadotropin-releasing hormone blocker for the treatment of prostate cancerJohn AndersonPageof 42